23 Jul TISSUE ENGINEERING LOGISTICS
Abstract
The invention relates to a method for delivering a tissue engineered product, and reporting the status of cells that are cultured in vitro for producing said product. The method comprises the steps of: triggering a shipment process, wherein cells to be cultured in vitro are shipped from a cell-extraction facility to a cell-culturing facility. Upon reception of said cells in said cell-culturing facility, a production process is triggered, wherein, upon reception of said cells in said cell-culturing facility, a tissue engineered product is produced from said cells. A status is communicated to an authorized client. A tissue engineered product is delivered by triggering a delivery process, for delivering to said client a tissue engineered product. A client-requested delivery time value may be received, said reception triggering a delivery process to be completed on said requested delivery time.
Year: 2002
Country: WO
Doc No: 235416